General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Astrup A et al. – Liraglutide treatment over 20 weeks is well tolerated, induces weight loss, improves certain obesity–related risk factors, and reduces prediabetes.


   

Related Articles

Early life influences on obesity risk: maternal overnutrition and programming of obesity
Expert Review of Endocrinology & Metabolism, 11/12/09    Relevance Score: 94%

Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09    Relevance Score: 94%

Obesity as a disease state: A new paradigm for diagnosis and treatment
Clinical Cornerstone, 10/21/09    Relevance Score: 93%

Obesity as a Social Problem in the United States
Policy, Politics, & Nursing Practice, 10/01/09    Relevance Score: 93%

Obesity and Alzheimer’s Disease: A Link Between Body Weight and Cognitive Function in Old Age
American Journal of Alzheimer's Disease and Other Dementias, 10/07/09    Relevance Score: 91%

Today in Obesity...keeping you current

The anorectic and obese adolescent
Best Practice & Research Clinical Obstetrics & Gynaecology, 03/17/10

Dipeptidyl-Peptidase 4 and Attractin Expression is Increased in Circulating Blood Monocytes of Obese Human Subjects
Experimental and Clinical Endocrinology & Diabetes, 03/17/10

In humans the adiponectin receptor R2 is expressed predominantly in adipose tissue and linked to the adipose tissue expression of MMIF-1
Diabetes, Obesity and Metabolism, 03/17/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address